Texas Ozempic Blindness Attorney

By Dr. Shezad Malik, M.D., J.D. — Board-Certified Physician & Product Liability Trial Attorney

Has Ozempic Caused Sudden Vision Loss or Blindness?

If you or a loved one used Ozempic, Wegovy, or Rybelsus in Texas and were subsequently diagnosed with
Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION),
you may be entitled to significant financial compensation. Contact Texas Ozempic Blindness Attorney, Dr. Shezad Malik.

Massive pharmaceutical companies must be held accountable when they fail to warn the public about catastrophic side effects.

As a Texas Ozempic Blindness Attorney, Texas medical doctor, and product liability attorney,
I evaluate your case from both a clinical and legal standpoint. Our firm handles nationwide pharmaceutical litigation right here from our home base in Dallas.

Texas Ozempic lawsuit attorney evaluation image showing a split-screen layout with a patient undergoing an eye examination through a phoropter on the left, and a blurred, out-of-focus Snellen eye chart on the right, symbolizing NAION vision loss and optic nerve stroke complications.
Lawsuits allege that brand-name semaglutide drugs like Ozempic can cause sudden, irreversible vision loss from NAION (optic nerve stroke). If your vision became blurred or compromised after use, contact our Dallas office to evaluate your Texas product liability claim.

Instant Case Screener

Do You Qualify For An Ozempic Compensation Claim?

✅ Case Qualifiers:

  • You used brand-name Ozempic or Wegovy injections.
  • You suffered sudden, painless loss of sight or a blind spot in one eye.
  • An eye specialist diagnosed you with Non-Arteritic Anterior Ischemic Optic Neuropathy NAION or an “Eye Stroke.”

❌ Case Disqualifiers:

  • You only used generic or “compounded” semaglutide drops/pills.
  • Your vision issues were present before starting the medication.
  • Your vision loss is due to cataracts or glaucoma.

👉 Meet the Qualifications?

Please click our Live Chat Agent button in the bottom corner of your screen to launch an instant intake review, or call us directly:

You do not have to fight this alone. At the DR SHEZAD MALIK LAW FIRM, we combine deep medical insight with fierce legal advocacy to hold powerful pharmaceutical companies accountable.

Call us today at 214-390-3189 for a free, confidential consultation, or read on to learn the facts about the Ozempic vision loss lawsuits.

Dr. Shezad Malik, M.D., J.D.

Medical Doctor & Trial Attorney

As both a licensed medical doctor and an experienced product liability lawyer, Dr. Shezad Malik brings an exceptional perspective to pharmaceutical injuries. He understands the complex vascular science behind Ozempic-related eye strokes just as deeply as the aggressive legal tactics required to win multi-million dollar cases against corporate drug manufacturing giants.

Why File an Ozempic NAION Lawsuit?
Irreversible HarmUnlike temporary gastrointestinal side effects, NAION causes permanent, incurable optic nerve damage.
Failure to WarnLawsuits allege Novo Nordisk knew of the risks but failed to warn American patients and doctors adequately.
Financial RecoveryA successful claim can cover your specialized neuro-ophthalmology visits, lost wages, and loss of independence.
Don’t navigate a complex medical-legal battle alone. Call the Texas Ozempic Blindness Attorney at the DR SHEZAD MALIK LAW FIRM today at 214-390-3189 for a free, confidential consultation.

If you or a loved one used Ozempic, Wegovy, or Rybelsus in Texas and were diagnosed with Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION), you may be entitled to financial compensation.

As a medical doctor and product liability attorney, I evaluate your case from both a clinical and legal standpoint, handling pharmaceutical litigation from our Dallas base.

The Clinical Framework: Ozempic and the Eye

As a physician and Texas Ozempic Blindness Attorney, I analyze studies, including those in JAMA Ophthalmology, which indicate a higher risk of NAION in GLP-1 users. This “eye stroke” causes permanent visual damage due to blood supply vascular disruption.

What is NAION?

Recognizing the Signs of an “Eye Stroke.”

Your eye works like a camera, and the optic nerve is the cable that sends the picture to your brain.
To do its job, this nerve needs a constant, healthy supply of blood and oxygen.

Watch for These Danger Signs:

Sudden, Painless Blindness:

A severe drop in vision that happens instantly, frequently noticed right when you wake up.

The “Window Shade” Effect:

Dark shadows or blind spots that completely block out either the top half or bottom half of your field of vision.

Vision Loss in One Eye:

The condition usually strikes one eye first, leaving patients terrified that the other eye will be next.

Blurry or Faded Sight:

Objects look dim, washed out, or completely lack contrast.

During an eye exam, an ophthalmologist eye specialist will physically see a swollen, bleeding optic nerve.
Over time, this swelling leaves behind permanent nerve scarring (atrophy).


CRITICAL SYMPTOM ALERT

If you took Ozempic or Wegovy, seek immediate ophthalmology evaluation if you notice:

  • Sudden, painless vision loss (often noticed right upon waking up)
  • A “dark shade” or blur covering the top or bottom half of your vision
  • Decreased color contrast or sudden dimness in one eye
  • Or you get a medical diagnosis of an “Eye Stroke” or NAION

No Treatment for NAION Blindness

The optic nerve damage from NAION is permanent, and usually incurable. The vision loss may worsen over the next few weeks, but it does not get better.

Diabetes Is a Risk Factor for NAION Blindness

About 6,000 people are diagnosed with NAION every year. It is most common in people who are over 50 years old, especially people with risk factors like type-2 diabetes, cardiovascular disease, obstructive sleep apnea,
high blood pressure, and use of certain medications.

Case Reports and Additional Evidence

A case report published in Neuro-Ophthalmology described a 73-year-old man with type 2 diabetes, obesity, and hypertension who developed bilateral NAION after significant weight loss and postural hypotension while on semaglutide.

This case suggests that rapid physiological changes, such as weight loss or blood pressure fluctuations,
may contribute to NAION risk in susceptible individuals.

Ozempic Litigation August 2026 Update

The legal landscape for semaglutide vision loss has evolved. While initial focus was on gastrointestinal issues,
the litigation for NAION is moving forward through federal discovery and state-level coordination,
focusing on how these drugs affect blood flow to the optic nerve.

To help you understand where your potential case stands, look at the active federal consolidation tracks:

Litigation TrackJurisdictional StatusPrimary FocusActive Case Status
MDL No. 3163Eastern District of PennsylvaniaOphthalmic Injuries (NAION / Blindness)Actively Recruiting. Separated from GI claims to fast-track vision discovery.
MDL No. 3094Eastern District of PennsylvaniaGastrointestinal Injuries (Gastroparesis)Over 3,900 cases pending; entering active bellwether scheduling phases.
State Court MCLsNew Jersey & Coordinated VenuesDual-Track GI and Vision ClaimsMulti-county tracking established to streamline state-level failure to warn claims.

In early 2026, federal courts initiated a dedicated “Science Day” for the vision-loss cases.

This allowed plaintiffs’ attorneys to present cutting-edge medical evidence detailing exactly how semaglutide
drops blood flow to the optic nerve head, effectively causing an “eye stroke.”

The federal multidistrict litigation (MDL) for Ozempic, titled “In re: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation” (MDL No. 3094), was established in February 2024.

The litigation alleges that Novo Nordisk failed to adequately warn about severe gastrointestinal side effects,
such as gastroparesis, ileus, and bowel obstruction, linked to Ozempic and other GLP-1 drugs. The first bellwether trials are not expected until 2027.

NAION Cases Consolidated in New Jersey State Court

In New Jersey state courts, lawsuits are focused on NAION-related injuries. One of the first such cases was filed on April 15, 2025, alleging that a New Jersey resident developed NAION after using Ozempic, blaming the condition on inadequate warnings by Novo Nordisk.

More than 20 New Jersey residents filed vision-loss suits in April 2025, leading to the consolidation of these blindness claims into a single state litigation.

These state actions operate under the Multicounty Litigation (MCL) framework, which coordinates similar cases and may align discovery efforts with the federal MDL.

Two applications for multicounty litigation designation of New Jersey state-court litigation alleging injuries caused by GLP-1 medications (Ozempic®, Wegovy®, Rybelsus®, Trulicity®, Mounjaro®, and Zepbound®). The applications requested that GLP-1 litigation involving (1) gastrointestinal injuries and (2) Nonarteritic Anterior Ischemic Optic Neuropathy (NAION) vision loss be designated as separate and distinct MCLs.

The New Jersey Supreme Court has designated the two types of cases as separate and distinct multicounty litigations.

The Court has assigned both MCLs to Bergen County for centralized case management by Superior Court Judge Gregg A. Padovano.

Do You Qualify to File a Texas Ozempic Lawsuit?
Texas law places strict requirements on product liability claims. To build a viable claim under the
Texas Civil Practice and Remedies Code, your case should meet the following criteria:
Documented GLP-1 UsageYou must have a verified pharmacy printout or prescription record for brand-name Ozempic, Wegovy, or Rybelsus.
(Note: Compounded weight-loss clinic injections do not qualify).
Formal NAION DiagnosisYou must have an official medical diagnosis from an ophthalmologist or neuro-ophthalmologist confirming ischemic optic nerve damage.
Clear Medical TimelineThe vision loss must have manifested while you were actively taking the drug, or shortly after ending your treatment.
Statute of LimitationsTexas enforces a strict two-year statute of limitations for product liability claims.
The clock starts from the exact date of your diagnosis—waiting too long can bar you from financial recovery forever.

Serving Dallas, Collin, Denton, and Tarrant Counties, as well as nationwide cases.

Contact Dr Shezad Malik Law Firm Now for NAION Blindness

If you or a loved one uses Ozempic or Wegovy for weight loss or diabetes treatment and has developed NAION,
contact the Texas Ozempic Blindness Attorney at DR SHEZAD MALIK LAW FIRM to learn more about your legal rights.
You can speak with one of our representatives by calling 214-390-3189 or by filling out the case evaluation form on this page.

Our law firm’s principal office is in Dallas, Texas. DR SHEZAD MALIK LAW FIRM represents clients in dangerous drug and dangerous medical device lawsuits nationwide.


Frequently Asked Questions: Ozempic & NAION Vision Loss

Can Ozempic cause permanent blindness or vision loss?

Yes. Recent clinical research, including a landmark study by Harvard medical researchers, indicates that semaglutide (the active ingredient in Ozempic and Wegovy) is linked to a higher risk of developing
Non-Arteritic Ischemic Optic Neuropathy (NAION). NAION occurs when blood supply to the optic nerve is blocked, causing an “eye stroke.” Because the optic nerve cannot regenerate, the resulting vision loss or partial blindness is typically permanent.

What are the symptoms of an eye stroke (NAION) from Ozempic?

The primary symptoms of Ozempic-related NAION include a sudden, completely painless loss of vision, which many patients first notice immediately upon waking up. It frequently manifests as a dark shadow or “blind spot” covering either the upper or lower half of your field of vision (known as an altitudinal visual field defect). It usually affects one eye initially, though it can impact both if left unmonitored.

Who qualifies to file an Ozempic NAION lawsuit in Texas?

To qualify for an Ozempic or Wegovy lawsuit, a plaintiff generally must prove three key elements:
Documented Use: Medical or pharmacy records confirming you actively used brand-name Ozempic or Wegovy injections.
Specific Diagnosis: An official clinical diagnosis of NAION or a documented “eye stroke” from an ophthalmologist or neuro-ophthalmologist.
Timing: The onset of sudden blindness or visual field loss occurred while you were actively taking the medication.

Is there a deadline to file an Ozempic NAION lawsuit in Texas?

Yes. Every state enforces strict deadlines known as the Statute of Limitations for product liability and personal injury claims.
In Texas, you generally have two (2) years from the date you discovered—or reasonably should have discovered—the link between your injury and the medication to file a lawsuit. Failing to act before this strict legal deadline runs out will forever bar you from seeking financial compensation.


Injured by Ozempic or Wegovy?

Speak Directly to a Doctor-Lawyer. Available 24/7.

Attorney Advertising & Medical Disclaimer

The content provided on this webpage and blog is for informational and educational purposes only. It does not constitute formal legal advice, nor does it establish an attorney-client relationship between the reader and the DR SHEZAD MALIK LAW FIRM. Prior case results, verdicts, or settlements do not guarantee or predict a similar outcome in any future legal matter.

Medical Notice: Dr. Shezad Malik is a licensed medical doctor and attorney; however, reading this information does not create a doctor-patient relationship. Do not stop taking any prescribed pharmaceutical medication, including Ozempic or Wegovy, without first consulting your prescribing physician or a qualified healthcare provider. Sudden cessation of medication can cause severe medical complications.

Principal office located in Dallas, Texas. Services may be associated with co-counsel or referred to a network of product liability attorneys nationwide to maximize client recovery.

Texas Product Liability & Mass Tort Legal Services

The DR SHEZAD MALIK LAW FIRM represents injured patients and families affected by dangerous drug side effects across the entire State of Texas. If you or a loved one suffered sudden vision loss, blindness, or an official diagnosis of Non-Arteritic Ischemic Optic Neuropathy (NAION) after using semaglutide injections, our legal team can review your medical records and file your claim regardless of your location. We proudly review potential pharmaceutical injury cases originating from the following Texas regions, counties, and major metropolitan areas:

Major Texas Cities Covered:
Dallas, Fort Worth, Houston, Austin, San Antonio, El Paso, Arlington, Corpus Christi, Plano, Lubbock, Laredo, Irving, Garland, Frisco, McKinney, Amarillo, Grand Prairie, Brownsville, Pasadena, Killeen, Mesquite, McAllen, Carrollton, Waco, Denton, Midland, Abilene, Sugar Land, Round Rock, and Wichita Falls.

Texas Counties Served:
Dallas County, Tarrant County, Harris County, Bexar County, Travis County, Collin County, Denton County, Hidalgo County, El Paso County, Fort Bend County, Montgomery County, Williamson County, Cameron County, Nueces County, Brazoria County, Bell County, Galveston County, Lubbock County, Webb County, and McLennan County.

No matter where you live in Texas, call 214-390-3189 for an immediate legal consultation.

Read More Here

ContactFormImage.jpg

Contact We’re Here to Help You

Fill out the form or call us at 214-390-3189 to schedule your free consultation.